Growth Metrics

Journey Medical (DERM) Raw Materials (2021)

Journey Medical (DERM) has disclosed Raw Materials for 1 consecutive years, with $5.6 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Raw Materials changed N/A year-over-year to $5.6 million, compared with a TTM value of $5.6 million through Dec 2021, changed N/A, and an annual FY2021 reading of $5.6 million, changed N/A over the prior year.
  • Raw Materials was $5.6 million for Q4 2021 at Journey Medical, up from $5.5 million in the prior quarter.
  • Across five years, Raw Materials topped out at $5.6 million in Q4 2021 and bottomed at $5.5 million in Q3 2021.